# A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes

> **NCT02384096** · NA · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 17 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DEVICE:** Conventional single source programming
- **DEVICE:** Precision Spectra SCS System advanced programming

## Key facts

- **NCT ID:** NCT02384096
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02384096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02384096, "A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02384096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*